title: Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung.
authors.affiliation: Gustave Roussy, Paris-Saclay University, Medical Oncology Department, Villejuif, France.
authors.forename: Jordi
authors.initials: J
authors.lastname: Remon
authors.affiliation: Gustave Roussy, Paris-Saclay University, Radiotherapy Department, Villejuif, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Le Péchoux
authors.affiliation: Gustave Roussy, Paris-Saclay University, Radiology Department, Villejuif, France.
authors.forename: Caroline
authors.initials: C
authors.lastname: Caramella
authors.affiliation: Gustave Roussy, Paris-Saclay University, Radiotherapy Department, Villejuif, France.
authors.forename: Frederic
authors.initials: F
authors.lastname: Dhermain
authors.affiliation: Gustave Roussy, Paris-Saclay University, Radiotherapy Department, Villejuif, France.
authors.forename: Guillame
authors.initials: G
authors.lastname: Louvel
authors.affiliation: Gustave Roussy, Paris-Saclay University, Medical Oncology Department, Villejuif, France; Paris-Sud University and Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
authors.affiliation: Gustave Roussy, Paris-Saclay University, Medical Oncology Department, Villejuif, France; Paris-Sud University and Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Besse
mesh_terms: D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology / Q000528:radiation effects*; D002294:Carcinoma, Squamous Cell / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D011832:Radiation Injuries / Q000473:pathology / Q000628:therapy*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000068258:Bevacizumab